Screener
Alnylam Pharmaceuticals ALNY Raw materials
Raw materials at other companies
Other financials
Where this comes from
Reported directly by Alnylam Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryRawMaterials.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's raw materials?
- Alnylam Pharmaceuticals (ALNY) reported raw materials of $13.91M in Q2 2026.
- How has Alnylam Pharmaceuticals's raw materials changed year-over-year?
- Alnylam Pharmaceuticals's raw materials decreased by 39.2% year-over-year, from $22.87M to $13.91M.
- What is the long-term trend for Alnylam Pharmaceuticals's raw materials?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's raw materials has grown at a -25.9% compound annual growth rate (CAGR), from $63.46M to $14.18M.
- What does raw materials mean?
- Unprocessed materials and components purchased for use in manufacturing, valued at cost.
Ask your AI about Alnylam Pharmaceuticals's raw materials.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude